Wong William
Department of Nephrology, Starship Children's Hospital, Auckland, New Zealand.
J Paediatr Child Health. 2007 May;43(5):337-41. doi: 10.1111/j.1440-1754.2007.01077.x.
To describe the demographic, clinical features, steroid response, histopathology and complications of all children diagnosed with idiopathic nephrotic syndrome (INS) in New Zealand over a 3-year period.
A questionnaire seeking relevant clinical information was sent to all paediatricians who reported a new case of nephrotic syndrome to the New Zealand Paediatric Surveillance Unit. A follow-up questionnaire was sent to reporting paediatricians after the first 12 months of follow-up.
The incidence was 1.9 children per 100,000 under age 15 years. There was no significant difference in INS between ethnic groups. Approximately 80.4% were steroid responsive with median time to response of 8.4 days and mean time to relapse was 15.1 +/- 12.1 weeks (10.1-19.8 95% confidence interval). Follow-up at 12 months after diagnosis showed that two-thirds were either steroid dependent or frequent relapsers. Steroid resistance patients had a more variable course with some developing chronic renal failure and other remaining persistently nephrotic.
The incidence and outcome of children with INS are similar to overseas studies. A large variety of steroid treatment regimens were noted. Current evidenced-based guidelines to treat INS were used infrequently.
描述新西兰3年间所有诊断为特发性肾病综合征(INS)的儿童的人口统计学、临床特征、类固醇反应、组织病理学及并发症。
向所有向新西兰儿科监测单位报告肾病综合征新病例的儿科医生发送一份询问相关临床信息的问卷。随访12个月后,向报告的儿科医生发送一份随访问卷。
15岁以下儿童的发病率为每10万人中有1.9名儿童。不同种族间INS无显著差异。约80.4%的患儿对类固醇有反应,中位反应时间为8.4天,平均复发时间为15.1±12.1周(95%置信区间为10.1 - 19.8)。诊断后12个月的随访显示,三分之二的患儿为类固醇依赖型或频繁复发型。类固醇抵抗型患者病程变化更大,一些患者发展为慢性肾衰竭,另一些患者则持续处于肾病状态。
INS患儿的发病率及转归与国外研究相似。记录到多种类固醇治疗方案。目前基于证据的INS治疗指南很少被采用。